Arterially directed therapies for hepatocellular carcinoma

Abstract

OBJECTIVE. Arterially directed therapies for hepatocellular carcinoma are used for patients who are not candidates for surgery or ablation and for those who need a bridge or downstaging to liver transplantation. These therapies seem to prolong the overall survival when compared with supportive care. CONCLUSION. Chemoembolization, particle embolization, drug-eluting beads, and radioembolization have been used for locoregional control. This review discusses patient selection, techniques, safety, clinical outcomes, and imaging findings related to these therapies. © American Roentgen Ray Society.